Cleared Special

K153502 - ClariVein IC

K153502 is an FDA 510(k) clearance for ClariVein IC, manufactured by Vascular Insights, LLC. The device is a Class 2 Cardiovascular device with product code KRA cleared through the Special 510(k) pathway after a 30-day FDA review.

K153502 · Vascular Insights, LLC · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2016
Decision
30d
Days
Class 2
Risk

K153502 is an FDA 510(k) clearance for the ClariVein IC. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Vascular Insights, LLC (Quincy, US). The FDA issued a Cleared decision on January 6, 2016 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K153502

510(k) Number K153502 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 2015
Decision Date January 06, 2016
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

KRA Device Classification - Class 2, Special Controls

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 168
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K153502.
CrossCath Support Catheter
K161801 · Cook Incorporated · Jul 2016
Bullfrog Micro-Infusion Device
K153501 · Mercator Medsystems, Inc. · Apr 2016
MMS Guide Catheter
K152625 · Micro Medical Solutions, Inc. · Mar 2016
Direxion Torqueable Microcatheter
K142259 · Boston Scientific Corp · Sep 2014
RENEGADE HI-FLO MICROCATHETER, MICROCATHETER KIT, FATHOM SYSTEM, FATHOM KIT
K140329 · Boston Scientific · May 2014
PEREGRINE SYSTEM INFUSION CATHETER
K140637 · Ablative Solutions, Inc. · Mar 2014